Green Plains (NASDAQ:GPRE) Price Target Cut to $22.00 by Analysts at BMO Capital Markets

Green Plains (NASDAQ:GPRE) had its price objective lowered by BMO Capital Markets from $25.00 to $22.00 in a research report sent to investors on Monday morning, Benzinga reports. BMO Capital Markets currently has a market perform rating on the specialty chemicals company’s stock.

Several other research firms also recently weighed in on GPRE. TheStreet downgraded shares of Green Plains from a c- rating to a d+ rating in a research report on Wednesday, February 7th. The Goldman Sachs Group cut their target price on Green Plains from $39.00 to $34.00 and set a buy rating on the stock in a research report on Tuesday, January 30th. Roth Mkm reaffirmed a buy rating and set a $55.00 price target on shares of Green Plains in a research report on Monday, March 25th. UBS Group cut their price objective on Green Plains from $33.50 to $31.00 and set a buy rating on the stock in a report on Monday, March 4th. Finally, Truist Financial reaffirmed a buy rating and set a $35.00 target price on shares of Green Plains in a report on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Green Plains has a consensus rating of Moderate Buy and a consensus price target of $30.75.

Green Plains Stock Up 1.6 %

Shares of NASDAQ GPRE opened at $19.58 on Monday. Green Plains has a 52-week low of $18.75 and a 52-week high of $36.02. The firm has a market capitalization of $1.27 billion, a price-to-earnings ratio of -15.92 and a beta of 1.62. The stock has a 50 day moving average price of $21.52 and a 200 day moving average price of $23.28. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.18 and a current ratio of 1.75.

Green Plains (NASDAQ:GPRE) last announced its earnings results on Friday, May 3rd. The specialty chemicals company reported ($0.81) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.48). Green Plains had a negative net margin of 2.43% and a negative return on equity of 7.86%. The company had revenue of $597.20 million for the quarter, compared to the consensus estimate of $654.40 million. During the same period last year, the business posted ($1.20) EPS. The firm’s revenue was down 28.3% compared to the same quarter last year. Sell-side analysts expect that Green Plains will post 0.28 earnings per share for the current year.

Insider Activity at Green Plains

In other Green Plains news, Director Ejnar A. Knudsen III bought 4,000 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were acquired at an average price of $24.73 per share, with a total value of $98,920.00. Following the transaction, the director now owns 40,913 shares of the company’s stock, valued at $1,011,778.49. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 3.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Grantham Mayo Van Otterloo & Co. LLC raised its holdings in Green Plains by 11.9% in the 3rd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 5,479,901 shares of the specialty chemicals company’s stock valued at $164,945,000 after acquiring an additional 584,257 shares during the last quarter. Grizzlyrock Capital LLC acquired a new position in Green Plains in the fourth quarter valued at $10,444,000. Broad Bay Capital Management LP increased its stake in Green Plains by 17.6% in the fourth quarter. Broad Bay Capital Management LP now owns 2,352,000 shares of the specialty chemicals company’s stock valued at $59,317,000 after purchasing an additional 352,000 shares during the last quarter. Clifford Capital Partners LLC purchased a new position in Green Plains during the first quarter worth about $7,688,000. Finally, Kailix Advisors LLC boosted its stake in Green Plains by 49.0% in the 1st quarter. Kailix Advisors LLC now owns 960,752 shares of the specialty chemicals company’s stock worth $22,213,000 after buying an additional 316,142 shares during the last quarter.

About Green Plains

Green Plains Inc produces low-carbon fuels in the United States and internationally. It operates through three segments: Ethanol Production, Agribusiness and Energy Services, and Partnership. The Ethanol Production segment produces ethanol, distillers grains, and ultra-high protein and renewable corn oil.